Healing of chronic hepatitis delta relapsing to pegylated interferon with tenofovir

Med Clin (Barc). 2022 Sep 9;159(5):e32. doi: 10.1016/j.medcli.2022.02.017. Epub 2022 Jun 1.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents* / adverse effects
  • Drug Therapy, Combination
  • Hepatitis, Chronic / drug therapy
  • Humans
  • Interferon-alpha* / adverse effects
  • Polyethylene Glycols / adverse effects
  • Recombinant Proteins / therapeutic use
  • Tenofovir / therapeutic use
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Tenofovir